tiprankstipranks
Heron Therapeutics (HRTX)
NASDAQ:HRTX
US Market
HRTX
Heron Therapeutics
RESEARCH TOOLSreports
Want to see HRTX full AI Analyst Report?

Heron Therapeutics (HRTX) Income Statement

1,644 Followers

Heron Therapeutics Income Statement

Last quarter (Q4 2025), Heron Therapeutics's total revenue was $40.59M, a decrease of -0.47% from the same quarter last year. In Q4, Heron Therapeutics's net income was $-2.95M. See Heron Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 154.90M$ 144.28M$ 127.04M$ 107.67M$ 86.35M
Gross Profit
$ 113.56M$ 105.64M$ 61.94M$ 52.80M$ 40.33M
Operating Expenses
$ 116.09M$ 117.17M$ 172.55M$ 227.46M$ 258.15M
Depreciation and Amortization
$ 2.31M$ 2.49M$ 2.90M$ 2.89M$ 3.02M
EBITDA
$ -17.88M$ -5.06M$ -103.79M$ -176.66M$ -215.25M
Operating Income
$ -2.54M$ -11.53M$ -110.61M$ -174.66M$ -217.83M
Other Income/Expenses
$ -17.66M$ -2.05M$ 56.00K$ -7.37M$ -2.85M
Pretax Income
$ -20.20M$ -13.58M$ -110.56M$ -182.02M$ -220.68M
Net Income
$ -20.20M$ -13.58M$ -110.56M$ -182.02M$ -220.68M
Per Share Metrics
Basic EPS
$ -0.12$ -0.09$ -0.80$ -1.67$ -2.24
Diluted EPS
$ -0.12$ -0.09$ -0.80$ -1.67$ -2.24
Weighted Average Shares Outstanding
 166.71M 152.45M 138.13M 109.00M 98.47M
Weighted Average Shares Outstanding (Diluted)
 166.71M 152.45M 138.13M 109.00M 98.47M
Currency in USD

Heron Therapeutics Earnings and Revenue History